Literature DB >> 21174606

Ocular drug delivery - a look towards nanobioadhesives.

Lisa C du Toit1, Viness Pillay, Yahya E Choonara, Thirumala Govender, Trevor Carmichael.   

Abstract

IMPORTANCE OF THE FIELD: A major challenge emanating in the design of topical ophthalmic preparations is their short precorneal residence time. Retention of a drug delivery system in the front of the eye is thus desirable. One solution identified to address this concern is a retentive system that can preferably be delivered in a liquid drop form and ultimately remain attached to the corneal tissue owing to incorporation of a bioadhesive component. Forward-thinking approaches are required to achieve advancements in this approach for the attainment of an effective drug concentration at the site of action. Accordingly, several investigators have identified the benefits of nanotechnology-based drug delivery systems for ophthalmic drug delivery. AREAS COVERED IN THIS REVIEW: A concerted effort was made to review critically all 'nanobioadhesives', that is, nanosystems designed for ocular drug delivery with the goal of attaining prolonged ocular retention, in a systematic, chronological manner, from their reported point of inception to the present. WHAT THE READER WILL GAIN: A perspective on possible future trends in this growing field of ocular drug delivery is formulated. TAKE HOME MESSAGE: The importance of and need for new developments in the field of ocular nanobioadhesives is emphasized.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21174606     DOI: 10.1517/17425247.2011.542142

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  15 in total

Review 1.  A comprehensive insight on ocular pharmacokinetics.

Authors:  Vibhuti Agrahari; Abhirup Mandal; Vivek Agrahari; Hoang M Trinh; Mary Joseph; Animikh Ray; Hicheme Hadji; Ranjana Mitra; Dhananjay Pal; Ashim K Mitra
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 2.  Causes and management of red eye in pediatric ophthalmology.

Authors:  Divya Seth; Farah I Khan
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

Review 3.  Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma.

Authors:  Kang Zhang; Liangfang Zhang; Robert N Weinreb
Journal:  Nat Rev Drug Discov       Date:  2012-06-15       Impact factor: 84.694

4.  Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface.

Authors:  Wanachat Chaiyasan; Sangly P Srinivas; Waree Tiyaboonchai
Journal:  J Ocul Pharmacol Ther       Date:  2013-01-28       Impact factor: 2.671

Review 5.  Antimicrobial nanomedicine for ocular bacterial and fungal infection.

Authors:  Wenjie Fan; Haijie Han; Yaoyao Chen; Xiaobo Zhang; Yifan Gao; Su Li; Qiao Jin; Jian Ji; Ke Yao
Journal:  Drug Deliv Transl Res       Date:  2021-04-11       Impact factor: 4.617

Review 6.  Fouling in ocular devices: implications for drug delivery, bioactive surface immobilization, and biomaterial design.

Authors:  Onyinye J Uwaezuoke; Pradeep Kumar; Viness Pillay; Yahya E Choonara
Journal:  Drug Deliv Transl Res       Date:  2021-01-16       Impact factor: 4.617

7.  Hair dye-incorporated poly-γ-glutamic acid/glycol chitosan nanoparticles based on ion-complex formation.

Authors:  Hye-Young Lee; Young-Il Jeong; Ki-Choon Choi
Journal:  Int J Nanomedicine       Date:  2011-11-17

8.  Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy.

Authors:  Jorge L Jacot; David Sherris
Journal:  J Ophthalmol       Date:  2011-10-30       Impact factor: 1.909

9.  Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.

Authors:  Frederic Lallemand; Philippe Daull; Simon Benita; Ronald Buggage; Jean-Sebastien Garrigue
Journal:  J Drug Deliv       Date:  2012-02-27

Review 10.  Nanotechnology approaches for ocular drug delivery.

Authors:  Qingguo Xu; Siva P Kambhampati; Rangaramanujam M Kannan
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.